About 12th Annual Biotech in Europe Investor Forum
The 12th Annual Biotech in Europe Investor Forum will be held on 1st –2nd October 2012 in Hilton Zurich Airport Hotel, Switzerland. This event will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. We expect around 400 delegates and 80 presenting companies.
The two-day conference programme will give you access to some of the leading players in the industry and will provide you with truly excellent networking opportunities as it boasts an online partnering system with 500 meeting slots available for all attendees to book before the event.
The program will comprise of plenary panels with confirmed chairs including:
Public Markets and M&A chaired by:
Stephanie Leouzon, Senior Advisor at Torreya Partners
Investment chaired by:
Tim Haines, Partner at Abingworth Management
Partnering chaired by:
Jason Rushton, Head of Life Sciences Advisory Initiative at Deloitte
Naveed Siddiqi, Partner at Phase4 Ventures Limited
Oncology chaired by:
Ekaterina Smirnyagina, Venture Partner, Alta Partners
Esteban Pombo Villar, Chief Operating Officer at Oxford BioTherapeutics AG
Regina Hodits, General Partner at Wellington Partners
Platform Technologies and Novel Therapeutics chaired by:
Chris Britten, Business Development at Astellas Pharma Europe Ltd
Heinz Schwer, Senior Director at MorphoSys AG
Neuroscience chaired by:
Alethia de Leon, Global BD&L, Head Search & Evaluation Neuroscience and Ophthalmic
at Novartis Pharmaceuticals
Regenerative Medicine chaired by:
Lorenza Castellon, Health & Biotech Equity Analyst at Equity Development
Vaccines chaired by:
Riccardo Manetti, Global Head of Search and Evaluation at Novartis Vaccines and Diagnostics
MedTech & Device chaired by:
Markus Hosang, General Partner at BioMedPartners AG
And more, to be announced later…
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.
Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.
Sachs Associates has developed an extensive knowledge
of the key individuals operating within the European and global biotech
industry. This together with a growing reputation for excellence puts
Sachs Associates at the forefront of the industry and provides a powerful
tool by which to increase the position of your company in this market.
Raise your company’s profile directly with
your potential clients. All of our sponsorship packages are tailor made
to each client, allowing your organisation to gain the most out of attending
our industry driven events.
To learn more about
Zoe Harris +
44 (0)203 463 4890 or
by email: Zoe Harris.